In short. What field change means, how pre-cancerous lesions are treated, and why follow-up continues after treatment rather than ending when the skin looks clear.
Key points
- The term describes change that has the potential to become cancer, and most lesions that carry it do not.
- It is treated because the risk is real and the treatment is straightforward, not because the outcome is inevitable.
- Treatment may be a topical course across an area, a destructive technique on individual lesions, or a small procedure to remove and examine one.
Some of what sun exposure produces is an appearance problem and some of it is a risk of skin cancer, and both are found in the same skin at the same time. Actinic damage is the term for the change that carries the risk. It is worth understanding separately, because it is the part of photodamaged skin that is managed rather than improved.
What actinic damage means
Decades of dose leave skin cells carrying damaged DNA, and some of that damage is in the genes that control how a cell divides. Most of it never becomes cancer; a small proportion does, and the change that precedes it is often visible as rough, scaly or reddened patches, or as a background change across an area rather than in one place. The scalp, the ears, the lips and the hands are where this is commonest, because those sites collect the most dose.
Field change and what it implies
Where the abnormality runs across an area rather than sitting in one spot, treating a single lesion does not treat the ground it grew in. Further lesions can appear in the same area, which is why field change is reviewed over years rather than treated once. It is also why someone with a history of these lesions is asked to return at intervals even when nothing is visible.
Pre-cancerous is not a diagnosis of cancer
The term describes change that has the potential to become cancer, and most lesions that carry it do not. It is treated because the risk is real and the treatment is straightforward, not because the outcome is inevitable. Treatment may be a topical course across an area, a destructive technique on individual lesions, or a small procedure to remove and examine one.
Why follow-up continues afterwards
Treatment removes what is there; it does not remove the accumulated damage behind it. The risk of a further lesion stays raised for years afterwards, even when the treated skin looks normal. The interval between reviews is set by how much damage is present, how many lesions there have been before, and whether there is a family history of skin cancer.
The part that can be changed
Protection is not a cosmetic step in this context. Daily protection reduces the appearance of further lesions in people who have already had them, and it is the only part within anyone's control. Beyond it, the useful actions are ordinary: examine your own skin, know which sites you cannot see, and have anything that changes looked at.
What should be examined promptly
- A lesion that grows, bleeds without injury, crusts repeatedly or fails to heal.
- A patch that stings, itches or is tender in a way it was not before.
- A new nodule on skin that has had a great deal of sun over the years.
How the skin is examined and recorded is described in how sun-damaged skin is assessed, and what to do when something changes is covered in when sun damage needs a doctor.
Frequently asked questions
Does actinic damage always become skin cancer?
No, and most of it does not. The term describes change that carries the potential to become cancer, and the reason it is treated is that the risk is real and the treatment is straightforward, not that the outcome is inevitable. Follow-up exists because the risk stays raised for years rather than because something is expected to develop.
If a pre-cancerous lesion is treated, is that the end of it?
Treatment removes what is there without removing the accumulated damage that produced it or the tendency behind it. Further lesions can appear in the same area, which is why the interval between reviews is set by how much damage is present and how many lesions there have been before, rather than by whether the last one was successfully treated.
Why does the whole skin get reviewed rather than only the treated area?
Because the damage that carries the risk is not confined to the spot that was treated, and the sites that collect the most dose over a lifetime are the ones a person cannot see. Reviewing the whole surface is how a new lesion in an area nobody was thinking about gets found at a stage when it is straightforward.
Risks & Limitations
- Damage already in the dermis is improved by treatment rather than removed by it, and the improvement fades while the exposure that produced it continues.
- Peels, light treatment and resurfacing can leave the treated skin darker or lighter than it was, and the risk is higher in darker skin tones.
- Resurfacing costs days to weeks of visible recovery, and redness often outlasts the healing.
- Skin with a large cumulative dose stays at raised risk of further lesions after treatment, which is why review continues rather than ends.
When to Seek Care
- A mole or patch that changes in size, shape, colour or height.
- A spot that bleeds without being knocked, crusts, itches persistently or fails to heal over a few weeks.
- A new lump or nodule on skin that has had a great deal of sun, particularly on the face, ear, scalp or lip.
- Persistent redness, scaling or roughness across an area of skin rather than in a single spot.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.